NeutriSci International Inc.
NRXCF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $2,092 | $7,598 | $14,997 | $3,703 |
| - Cash | $175 | $31 | $7 | $0 |
| + Debt | $179 | $60 | $0 | $46 |
| Enterprise Value | $2,096 | $7,627 | $14,990 | $3,749 |
| Revenue | $458 | $81 | $75 | $97 |
| % Growth | 465.9% | 8.5% | -22.8% | – |
| Gross Profit | -$43 | -$21 | -$6 | $3 |
| % Margin | -9.5% | -25.4% | -7.9% | 3% |
| EBITDA | -$733 | -$1,526 | -$1,924 | -$1,607 |
| % Margin | -160.2% | -1,886.5% | -2,579.9% | -1,664.3% |
| Net Income | -$771 | -$1,572 | -$1,953 | -$1,613 |
| % Margin | -168.4% | -1,943.5% | -2,618.3% | -1,670.7% |
| EPS Diluted | -0.005 | -0.01 | -0.014 | -0.014 |
| % Growth | 53.5% | 27.2% | 2.2% | – |
| Operating Cash Flow | -$166 | -$1,041 | -$1,521 | -$1,241 |
| Capital Expenditures | -$5 | -$107 | -$110 | $0 |
| Free Cash Flow | -$171 | -$1,148 | -$1,632 | -$1,241 |